A 58-year-old male, post-PCI for a STEMI, is exhibiting signs of acute heart failure with a respiratory rate of 28 breaths per minute and bilateral crackles on lung auscultation. His oxygen saturation is 92% with supplemental oxygen. Which nursing intervention should be prioritized to assist in managing the patient's acute heart failure symptoms?

B) Administer prescribed diuretics promptly

A) Increase the supplemental oxygen flow rate

B) Administer prescribed diuretics promptly

C) Encourage the patient to perform deep-breathing exercises

D) Restrict the patient's fluid intake immediately

A 58-year-old male patient is in the cardiac care unit post-PCI for a STEMI and is now exhibiting signs of acute heart failure. Which nursing intervention is the most appropriate to prioritize given the patient’s current condition?

C) Administer prescribed diuretics to reduce pulmonary congestion and monitor urine output

A) Increase the patient's supplemental oxygen to maintain an SpO2 of 95% or higher

B) Encourage the patient to ambulate to promote circulation and prevent thrombosis

C) Administer prescribed diuretics to reduce pulmonary congestion and monitor urine output

D) Withhold beta-blockers until the patient's heart rate decreases to below 100 bpm

A patient with acute decompensated heart failure is experiencing worsening pulmonary edema despite diuretic therapy. After administering intravenous nitroglycerin, the patient shows a slight improvement in oxygenation, but his blood pressure begins to decrease. What is the next best nursing intervention to address this situation?

B) Initiate non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce work of breathing.

A) Increase the rate of nitroglycerin infusion to further reduce preload and afterload.

B) Initiate non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce work of breathing.

C) Administer a fluid bolus to increase blood pressure and improve perfusion.

D) Hold diuretics to prevent further hypotension and reassess the patient's volume status.

A patient with acute decompensated heart failure is receiving intravenous nitroglycerin and increased diuretics. His oxygen saturation has improved to 92%, but his blood pressure has decreased to 110/70 mmHg. Which nursing intervention is most appropriate given the current situation?

C) Prepare for the initiation of non-invasive positive pressure ventilation (NIPPV) to support breathing.

A) Increase the rate of nitroglycerin infusion to enhance preload reduction.

B) Administer a fluid bolus to increase blood pressure and improve perfusion.

C) Prepare for the initiation of non-invasive positive pressure ventilation (NIPPV) to support breathing.

D) Hold the diuretic dose temporarily to prevent further hypotension.

A patient with heart failure exacerbation is exhibiting signs of hypoperfusion and has a blood pressure of 95/60 mmHg and a heart rate of 115 beats per minute. The healthcare team is considering initiating dobutamine to improve cardiac output. What should the nurse prioritize before starting this medication?

C) Ensure the patient has continuous cardiac monitoring in place.

A) Assess the patient's urine output over the past 4 hours.

B) Review the patient's allergy history for any reactions to dobutamine.

C) Ensure the patient has continuous cardiac monitoring in place.

D) Obtain a signed informed consent for the administration of dobutamine.

A patient with heart failure exacerbation is exhibiting signs of increased restlessness and confusion, hypotension, tachycardia, and elevated BNP levels. Arterial blood gas analysis shows a mixed respiratory acidosis. What is the most appropriate initial nursing intervention to address the patient's current condition?

B) Initiate oxygen therapy to improve cerebral oxygenation.

A) Administer a diuretic to decrease fluid overload.

B) Initiate oxygen therapy to improve cerebral oxygenation.

C) Prepare the patient for intubation to manage respiratory acidosis.

D) Start an IV infusion of normal saline to increase blood pressure.

A patient receiving dobutamine for inotropic support is showing signs of fluid overload, including jugular venous distention and bilateral crackles. The healthcare team is considering the administration of furosemide. What is the primary nursing consideration when administering furosemide in this situation?

A) Monitor the patient for signs of hypokalemia and adjust electrolytes accordingly.

B) Increase the dobutamine infusion rate to compensate for fluid loss.

C) Encourage the patient to increase oral fluid intake to prevent dehydration.

D) Discontinue the dobutamine infusion immediately to prevent further fluid overload.

A patient receiving dobutamine for inotropic support in the setting of heart failure shows signs of jugular venous distention and bilateral crackles, despite an initial improvement in mean arterial pressure and heart rate. A repeat echocardiogram reveals an ejection fraction of 30%, and pulmonary artery catheterization indicates elevated pulmonary capillary wedge pressure. Which nursing intervention is most appropriate to address the current clinical findings?

B) Administer a diuretic such as furosemide to reduce fluid overload.

A) Increase the dobutamine infusion rate to improve cardiac output further.

B) Administer a diuretic such as furosemide to reduce fluid overload.

C) Restrict oral fluid intake to minimize the risk of fluid overload.

D) Discontinue the dobutamine infusion to prevent worsening heart failure.

A patient receiving furosemide for fluid overload is experiencing diuresis with a decrease in jugular venous distention and improvement in respiratory status. However, the patient’s blood pressure is now trending downward, and serum creatinine levels have increased. Which nursing intervention is most appropriate to address the change in the patient's condition?

C) Notify the healthcare provider to discuss reducing the furosemide dosage

A) Increase the furosemide dose to enhance fluid removal

B) Administer a fluid bolus to counteract hypotension

C) Notify the healthcare provider to discuss reducing the furosemide dosage

D) Monitor the patient closely and wait for further changes before taking action

A patient receiving furosemide for fluid overload develops hypotension and worsening renal function, as indicated by elevated serum creatinine. Which nursing intervention should be prioritized to address these complications while considering the patient's heart failure status?

B) Notify the healthcare provider to discuss the need for vasopressor support.

A) Discontinue furosemide immediately to prevent further renal damage.

B) Notify the healthcare provider to discuss the need for vasopressor support.

C) Increase the furosemide dose to enhance fluid removal and reduce edema.

D) Administer intravenous fluids to counteract the hypotensive episode.

stemi - Nursing Case Study

Pathophysiology

• Primary mechanism: STEMI (ST-Elevation Myocardial Infarction) occurs when a coronary artery is completely occluded, often due to a ruptured atherosclerotic plaque and subsequent thrombus (blood clot) formation. This blockage stops blood flow, leading to ischemia and necrosis of the heart muscle supplied by the affected artery.

• Secondary mechanism: The resulting ischemia triggers a cascade of cellular changes, including a shift from aerobic to anaerobic metabolism. This leads to decreased ATP production, accumulation of lactic acid, and loss of cell membrane integrity, ultimately causing myocardial cell death.

• Key complication: If not promptly treated, the infarcted area can lead to ventricular dysfunction and heart failure, significantly increasing morbidity and mortality. Early reperfusion therapy, such as percutaneous coronary intervention (PCI), is crucial to restore blood flow and minimize heart muscle damage.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, type 2 diabetes

• Current medications: Lisinopril, atorvastatin, metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Nausea, shortness of breath, diaphoresis

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.5°C, O2 saturation 90% on room air

Section 1

As the medical team initiates treatment for the 58-year-old male experiencing a STEMI, they prioritize rapid reperfusion therapy. The patient is quickly transported to the cardiac catheterization lab for a percutaneous coronary intervention (PCI). The procedure successfully restores blood flow through the previously occluded coronary artery. Post-PCI, the patient is transferred to the cardiac care unit (CCU) for close monitoring. Initial assessments reveal that while the patient’s chest pain has decreased significantly, new concerns arise as he begins to exhibit signs of heart failure.

The patient’s vital signs post-intervention indicate a blood pressure of 140/90 mmHg, a heart rate of 105 bpm, and an increased respiratory rate of 28 breaths per minute. His oxygen saturation remains suboptimal at 92% despite supplemental oxygen. Auscultation of the lungs reveals bilateral crackles, suggesting pulmonary congestion. The medical team orders a chest X-ray and a repeat echocardiogram to assess the extent of ventricular dysfunction. Laboratory studies show elevated BNP levels, indicative of cardiac strain, and a troponin level that continues to rise, confirming myocardial damage.

The clinical team recognizes the development of acute heart failure as a complication of the myocardial infarction. The patient is started on diuretics to manage fluid overload, and his medication regimen is adjusted to include a beta-blocker to reduce myocardial oxygen demand and improve cardiac function. This change in status requires careful titration of medications and monitoring of renal function, given the patient's existing comorbidities. The goal is to stabilize the patient, alleviate symptoms of heart failure, and prevent further deterioration, while planning for long-term management strategies post-discharge.

Section 2

As the nursing team continues to monitor the patient in the cardiac care unit, they observe a change in his respiratory status over the following hours. Despite the initiation of diuretic therapy, the patient's respiratory rate has increased to 32 breaths per minute, and his oxygen saturation has dropped further to 88% on a non-rebreather mask. He appears increasingly anxious and is using accessory muscles to breathe. This prompts the medical team to urgently reassess the patient's condition, suspecting worsening pulmonary edema as a complication of his heart failure.

The repeat chest X-ray shows diffuse bilateral infiltrates consistent with pulmonary edema, and the echocardiogram reveals a reduced ejection fraction of 35%, signifying significant left ventricular dysfunction. These findings are concerning for acute decompensated heart failure. In response, the team decides to escalate treatment by administering intravenous nitroglycerin to reduce preload and afterload, in addition to increasing the diuretic dose. They also consider the potential need for non-invasive positive pressure ventilation (NIPPV) to improve his oxygenation and reduce the work of breathing.

As these interventions are implemented, the patient's vital signs are closely monitored. Initially, there is a slight improvement in his oxygen saturation, which rises to 92%, and a decrease in respiratory rate to 28 breaths per minute. However, his blood pressure begins to trend downward to 110/70 mmHg, necessitating careful balancing of medications to avoid hypotension while managing his heart failure symptoms. The healthcare team remains vigilant, prepared to adjust the treatment plan based on the patient’s response, and begins discussions about potential advanced therapies, such as inotropic support, should the need arise. This situation presents a critical opportunity for clinical reasoning, as the team must weigh the benefits and risks of each intervention, aiming for stabilization and recovery.

Section 3

As the healthcare team continues to closely monitor the patient, they notice a further change in his status. Despite initial improvements in oxygenation with the interventions, the patient begins to exhibit signs of increased restlessness and confusion. The nursing staff quickly identifies these as potential indicators of hypoperfusion and inadequate cerebral oxygenation. Concurrently, the patient's blood pressure has dropped further to 95/60 mmHg, and his heart rate has risen to 115 beats per minute, suggesting a compensatory response to maintain cardiac output in the face of declining perfusion.

In light of these developments, the team decides to perform additional diagnostic tests to gather more information about his evolving condition. Blood tests reveal a rising creatinine level, now at 2.1 mg/dL, suggesting potential acute kidney injury secondary to reduced cardiac output and renal perfusion. The B-type natriuretic peptide (BNP) level is also elevated at 1200 pg/mL, confirming significant cardiac stress and heart failure exacerbation. Arterial blood gas analysis shows a pH of 7.32, pCO2 of 55 mmHg, and HCO3 of 24 mEq/L, indicating a mixed respiratory acidosis likely due to hypoventilation and inadequate gas exchange.

Faced with these concerning findings, the healthcare team deliberates on the next steps. They discuss the potential initiation of inotropic support, such as dobutamine, to enhance cardiac contractility and improve systemic circulation. However, they must carefully consider the risk of further destabilizing the patient's hemodynamics. This scenario challenges the team to use clinical reasoning to balance the need for aggressive intervention with the risks of potential complications, aiming for the optimal outcome in stabilizing the patient’s deteriorating condition. The team remains focused on regular reassessment and dynamic adjustment of the treatment plan as they navigate this critical phase of the patient's care journey.

Section 4

As the healthcare team initiates inotropic support with dobutamine, they remain vigilant in monitoring the patient for any responses or changes in his condition. Initially, the infusion appears to have a positive effect, with a slight improvement in mean arterial pressure and a decrease in heart rate to 105 beats per minute. However, despite these promising changes, the patient's restlessness persists, and he begins to exhibit signs of jugular venous distention and bilateral crackles upon auscultation, raising concerns about potential fluid overload and worsening heart failure.

To further assess the situation, a repeat echocardiogram is performed, which reveals a decreased ejection fraction of 30%, indicating compromised left ventricular function. Additionally, pulmonary artery catheterization shows elevated pulmonary capillary wedge pressure, signifying increased left atrial pressure and confirming the presence of pulmonary congestion. These findings suggest that while the inotropic support is aiding cardiac output, it may be exacerbating the patient's fluid status, necessitating a delicate balance in fluid management.

In response to these developments, the team considers the introduction of a diuretic, such as furosemide, to alleviate the patient's fluid overload while carefully monitoring renal function, given the rising creatinine levels. This decision requires clinical reasoning to weigh the benefits of reducing pulmonary congestion against the risk of further renal compromise. The priority remains to improve the patient's perfusion and oxygenation status while preventing further complications, highlighting the need for ongoing reassessment and adjustment of the treatment plan. This complex interplay of interventions and patient responses sets the stage for the next critical phase in the patient's care journey.

Section 5

As the healthcare team proceeds with the administration of furosemide to manage the patient's fluid overload, they closely monitor the patient's response. Over the next several hours, the patient experiences diuresis, with a noticeable increase in urine output. This results in a slight reduction in his jugular venous distention and an improvement in his respiratory status, as the bilateral crackles diminish. Despite these positive changes, the team remains cautious, as the patient's blood pressure begins to trend downward, with systolic readings hovering around 85 mmHg, indicating a potential risk of hypotension due to the aggressive diuresis.

Laboratory results reveal a further elevation in serum creatinine to 2.3 mg/dL, indicating worsening renal function. This development prompts concern, as it suggests that while the fluid management strategy is alleviating pulmonary congestion, it may be compromising renal perfusion. The team is faced with the challenge of achieving a balance between optimizing cardiac output and maintaining renal function. A decision is made to adjust the diuretic dosage and consider additional renal support measures, such as the potential use of vasopressors to stabilize blood pressure without exacerbating the patient's heart failure.

As the patient's clinical picture evolves, the team remains vigilant for any signs of new complications. The patient continues to exhibit restlessness, and a repeat assessment reveals the onset of mild peripheral edema, raising the possibility of systemic fluid shifts. The priority now is to re-evaluate the comprehensive management plan, which includes revisiting the use of inotropes, reassessing fluid status, and ensuring that all interventions align with the overall goal of stabilizing the patient while minimizing adverse effects. This complex scenario underscores the need for ongoing clinical reasoning and collaboration among the healthcare team to navigate the intricacies of the patient's condition.